Pricing Log in Create free account

BioAtla, Inc. (BCAB) vs HCW Biologics Inc. (HCWB)

BioAtla, Inc. and HCW Biologics Inc. are both Biotechnology companies. BioAtla, Inc. and HCW Biologics Inc. are of similar size ($2.9M and $2.8M). HCW Biologics Inc. grew revenue faster over the last twelve months: 707.0% against 574.7%. BioAtla, Inc. has the higher net margin (−177.2% vs −329.4%) and the higher return on invested capital (0.00% vs −36.2%). Across the 16 metrics below, BioAtla, Inc. leads on 9 and HCW Biologics Inc. on 7.

Valuation

Metric BCAB HCWB Biotechnology median
P/E n/m n/m 8.50
P/S 0.13 0.25 9.71
P/B n/m 0.22 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.63 1.17 9.21
Earnings yield (1,871.32%) (2,225.58%) (33.15%)
Free cash flow yield (1,044.09%) (752.91%) (25.50%)

Profitability

Metric BCAB HCWB Biotechnology median
Gross margin 95.44% 95.91% 65.16%
Operating margin (180.99%) (114.02%) 0.00%
Net margin (177.21%) (329.38%) 0.00%
Free cash flow margin (132.29%) (180.57%) 0.00%
Return on equity 118.74% (600.32%) (56.36%)
Return on assets (171.72%) (79.52%) (48.04%)
Return on invested capital 0.00% (36.15%) 0.00%

Growth

Metric BCAB HCWB Biotechnology median
Revenue growth (TTM) 574.65% 706.96% 6.02%
EPS growth (last fiscal year) 29.86% 65.49% 30.26%
Revenue growth, 5-year CAGR (28.40%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCAB HCWB Biotechnology median
Debt to equity 0.00 0.88 0.00
Current ratio 0.20 0.06 4.72
Net debt to EBITDA 0.12 (0.40) 0.96

Dividend

Metric BCAB HCWB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BCAB HCWB Biotechnology median
Market cap 2.89m 2.75m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack